IonQ’s $1.8 Billion Supply Chain Bet: Why the Stock Jumped 22.5% This Week

IonQ stock jumps 22.5% after shareholders approve $1.8B SkyWater acquisition, $100M lab groundbreaking, and $2B U.S. quantum initiative fuels sector rally.

IonQ has spent years being known as a quantum computing research house with some impressive patents and a handful of government contracts. That narrative is changing fast. In a single week, shareholders signed off on a $1.8 billion takeover, the company broke ground on a $100 million research facility, and Washington unleashed a $2 billion quantum initiative that sent the entire sector soaring. The stock closed Friday at $63.64, up 22.5% for the week — yet still 25% below its 52-week high of $84.64.

The centerpiece of this transformation is the acquisition of SkyWater Technology, a semiconductor foundry that will give IonQ direct control over chip manufacturing. Until now, IonQ has relied on external partners to fabricate its trapped-ion quantum processors. With SkyWater, the company becomes an integrated hardware producer, a shift that analysts at B. Riley call “a critical step toward securing a domestic supply chain.” The deal, valued at $1.8 billion, was approved by shareholders after months of due diligence.

Alongside the acquisition, IonQ is building a new research and development center in Colorado spanning 22,000 square feet. The $100 million facility will focus on bringing quantum computers based on trapped ions into industrial applications — moving the technology beyond the lab and into factory floors and data centers. “This isn’t just about advancing the science,” said CEO Peter Chapman in a prepared statement. “It’s about making quantum computing something you can buy, install and operate.”

The timing aligns with the company’s strongest financial quarter on record. First-quarter 2026 revenue hit $64.7 million, a 755% surge from the same period a year earlier. The order backlog stood at $470 million, and IonQ raised its full-year guidance to between $260 million and $270 million. Yet the bottom line remains in the red: the company reported a loss per share of $0.34, missing the analyst consensus estimate of $0.26. The heavy spending on the SkyWater deal and the Colorado lab are squeezing margins in the near term.

Sector-wide enthusiasm was stoked on May 21 when the U.S. government announced a $2.013 billion quantum computing program under the CHIPS Act. IonQ was not among the nine direct awardees — IBM received roughly $1 billion, and Rigetti Computing, D-Wave and Quantinuum each secured up to $100 million — but the signal was unmistakable: Washington now treats quantum computing as a strategic priority, not a science experiment. The stock jumped anyway, and trading activity exploded. Friday’s volume of 57.7 million shares was more than double the three-month average of 28.3 million. Call options dominated the action, suggesting speculators are piling into bets on further gains.

Analysts are divided on how much more upside the stock has. The median price target among ten analysts is $65, with a range that stretches from DA Davidson’s conservative $35 to Rosenblatt’s optimistic $100. Wedbush rates the stock “Outperform” with a $75 target. The broader analyst consensus is “Moderate Buy” based on ten buy, six hold and one sell recommendation, and the average target sits at $68.63. The stock closed Friday about $5 below that average, but the 200-day moving average of $43.28 suggests the current price is already well above where the stock traded for most of the past year.

IonQ’s valuation remains a sticking point. The price-to-sales ratio exceeds 100 times, leaving little room for error. Investors seem willing to tolerate that lofty multiple because the company has roughly $3.3 billion in cash on hand, an unusually deep war chest for a quantum firm that is still losing money. That cash position also means IonQ does not need immediate federal grants to fund its expansion — it can finance the SkyWater integration and Colorado lab out of its own pocket.

Insider activity has been mixed. William J. Teuber Jr. bought 3,000 shares over the past six months, while several other insiders, including Kathryn K. Chou, sold a combined 25,000 shares. Institutional interest remains strong: Vanguard and Defiance ETFs have increased their positions in recent reporting periods, signaling confidence in the long-term thesis.

The path ahead is clear but narrow. IonQ must now execute on three fronts: integrate SkyWater into its supply chain, ramp up work at the Colorado lab, and convert its growing DARPA contracts and commercial pipelines into recurring revenue. The stock has momentum, but with the 52-week high still a stretch away, the next quarterly report will determine whether this week’s surge was the start of a sustained rally or just a brief breakout in a volatile sector.